|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Amortization of original issue discount | |||
| Depreciation and amortization | |||
| Impairment of goodwill | |||
| Realized loss on equity investment | |||
| Unrealized loss on equity investment | |||
| Change in fair value of convertible debt | |||
| Gain on extinguishment of liabilities | |||
| Equity-based compensation | |||
| Inventory write-down | |||
| Allowance for doubtful accounts | |||
| Changes in operating assets and liabilities | |||
| Accounts receivable | |||
| Insurance recovery receivable | |||
| Inventories | |||
| Prepaid expenses and other | |||
| Interest receivable | |||
| Accounts payable | |||
| Accrued compensation | |||
| Accrued expenses - related parties | |||
| Accrued creator commissions | |||
| Settlement payable | |||
| Accrued expenses | |||
| Accrued sales tax | |||
| Deferred revenue | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities | |||
| Cash acquired through Amaze Software acquisition (Note 2) | |||
| Capitalized fees from FoodChannel acquisition (Note 2) | |||
| Capitalized internally developed software | |||
| Issuance of notes receivable | |||
| Equity investment | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities | |||
| Proceeds from debt net of issuance costs | |||
| Proceeds from convertible notes payable and warrants | |||
| Proceeds from Series B preferred stock – net of issuance costs | |||
| Proceeds from Series B issuance of preferred stock – net of issuance costs | |||
| Payments on note payable | |||
| Proceeds from rights offering – net of issuance costs | |||
| Proceeds from Series C preferred stock – net of issuance costs | |||
| Repayment of debt | |||
| Deferred offering costs | |||
| Commencement shares issued with debt | |||
| Issuance of common stock from Equity Line of Credit – net of issuance costs | |||
| Issuance of common stock from At-The-Market Offering – net of issuance costs | |||
| Net cash provided by financing activities | |||
| Net decrease in cash | |||
| Cash and restricted cash - beginning of year | |||
| Cash and restricted cash - end of year | |||
| Supplemental disclosure of non-cash activities investing and financing activities: | |||
| Dividends declared but not paid | |||
| Equity warrants issued in conjunction with convertible notes payable | |||
| Series A preferred stock converted to common stock | |||
| Acquisition through issuance of Series D preferred stock and Merger Warrants | |||
| Acquisition of FoodChannel through issuance of convertible debt | |||
| Repayment of debt with investment | |||
| Forgiveness of note receivable and interest with note payable and interest with Acquisition | |||
| Warrants issued in conjunction with debt | |||
| Issuance cost in conjunction with name change | |||
| Accrued Series A dividends | |||
| Series A preferred dividends converted to common stock | |||
| Accrued expenses converted to Series C preferred stock and warrants |
Loading...